Carbonic Anhydrase IX Expression, a Novel Surrogate Marker of Tumor Hypoxia, Is Associated With a Poor Prognosis in Non–Small-Cell Lung Cancer
- 1 February 2003
- journal article
- lung cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (3) , 473-482
- https://doi.org/10.1200/jco.2003.11.132
Abstract
Purpose: To evaluate carbonic anhydrase (CA) IX as a surrogate marker of hypoxia and investigate the prognostic significance of different patterns of expression in non–small-cell lung cancer (NSCLC...Keywords
This publication has 28 references indexed in Scilit:
- A biological staging model for operable non-small cell lung cancerThorax, 2001
- Carbonic anhydrase inhibitors: Sulfonamides as antitumor agents?Bioorganic & Medicinal Chemistry, 2001
- Expression of the Hypoxia-Inducible and Tumor-Associated Carbonic Anhydrases in Ductal Carcinoma in Situ of the BreastThe American Journal of Pathology, 2001
- Nuclear NonO/p54nrb Protein Is a Nonclassical Carbonic AnhydrasePublished by Elsevier ,2000
- Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinomaEuropean Respiratory Journal, 1999
- Pimonidazole: A Novel Hypoxia Marker for Complementary Study of Tumor Hypoxia and Cell Proliferation in Cervical CarcinomaGynecologic Oncology, 1998
- Immunohistochemical Study of Colorectal Tumors for Expression of a Novel Transmembrane Carbonic Anhydrase, MN/CA IX, with Potential Value as a Marker of Cell ProliferationThe American Journal of Pathology, 1998
- Inkomplette Resektionen bei Bronchialcarcinom: Morbidität und PrognoseDer Chirurg, 1997
- Expression of MaTu‐MN protein in human tumor cultures and in clinical specimensInternational Journal of Cancer, 1993
- A novel quasi-viral agent, MaTu, is a two-component systemVirology, 1992